WIN-Partners Co., Ltd. (TYO:3183)

Market Cap	32.67B -11.4%
Revenue (ttm)	90.39B +11.0%
Net Income	2.12B +4.9%
EPS	75.97 +7.8%
Shares Out	27.50M
PE Ratio	15.64
Forward PE	n/a
Dividend	53.00 (4.41%)
Ex-Dividend Date	Mar 30, 2026

Volume	20,200
Open	1,191.00
Previous Close	1,201.00
Day's Range	1,188.00 - 1,203.00
52-Week Range	1,175.00 - 1,527.00
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2026

About WIN-Partners

WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous coronary intervention products, including PTCA balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1983
• Employees: 630
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3183

Financial Performance

In fiscal year 2026, WIN-Partners's revenue was 90.39 billion, an increase of 11.03% compared to the previous year's 81.41 billion. Earnings were 2.12 billion, an increase of 4.90%.